AMS Biotechnology/ImmunoKontact

AMS Biotechnology was set up in 1987 to provide innovative products to the Life Science market place. Currently AMS provides products that accelerate discovery in drug development and health research. In particular, AMS provides tools for state-of-the-art techniques in Cell Biology, Molecular Immunology and Glycobiology. The portfolio being developed by AMS includes the GenoProteomIKsrange, over 300 RNAs,cDNAs, proteins and tissues from a wide variety of sources and disease states are available. They include materials from plants and animals. The recently introduced gene array products ensures AMS can offer Pharma and Biotech companies an excellent way to easily source important materials for drug discovery programs.Made to measure products are available from the al a carte menu of services which includes custom antibody production, gene expression studies and expression of recombinant proteins in bacterial, baculovirus and mammalian systems.

To view additional details about g2i companies log in or register as an investor.